Cosmo Pharmaceuticals NV banner

Cosmo Pharmaceuticals NV
SIX:COPN

Watchlist Manager
Cosmo Pharmaceuticals NV Logo
Cosmo Pharmaceuticals NV
SIX:COPN
Watchlist
Price: 117 CHF 0.69% Market Closed
Market Cap: CHf2.1B

Profitability Summary

Cosmo Pharmaceuticals NV's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Cosmo Pharmaceuticals NV

Margins Comparison
Cosmo Pharmaceuticals NV Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IE
Cosmo Pharmaceuticals NV
SIX:COPN
1.9B CHF
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
987B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
592.7B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
298.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
237.8B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
248.3B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
309B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.4B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.1B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Cosmo Pharmaceuticals NV Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IE
Cosmo Pharmaceuticals NV
SIX:COPN
1.9B CHF
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
987B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
592.7B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
298.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
237.8B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
248.3B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
309B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.4B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.1B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Cosmo Pharmaceuticals NV

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett